Regorafenib versus lomustine for relapsed glioblastoma
9 Sep 2017
Regorafenib versus lomustine for relapsed glioblastoma
Editor's Choice for August 2017
Editor's Choice for July 17
iManageCancer: Serious Games for Kids
Targeted therapy for brain and CNS tumours
The unmet needs of cancer survivors
Precision medicine: a nurses perspective
New drug advancements presented at ASCO
iManageCancer: Psycho-emotional and family resilience monitoring
Celebrating a 10 year partnership: ecancer and the IEO
Genomic analysis of childhood tumours; biological and therapeutic implications
Improving care for cancer patients